Aier Healthcare Investment Group

Aier Healthcare Investment Group is the private holding company through which founder Chen Bang and vice chairman Li Li own their controlling stake in the publicly listed Aier Eye Hospital Group. It is not an operating subsidiary but a separate investment vehicle that manages the wealth generated by the hospital chain. The investment group holds Chen's roughly 50% economic interest and Li's balance of the holding, according to public shareholder disclosures.

No. While healthcare is the dominant theme — spanning ophthalmology, veterinary services via its co-investment with KKR in Ruichen Pet Hospital Group, and digital health ventures — the group also deploys into commercial real estate. It owns a portion of Wuhan Poly Cultural Plaza and its own headquarters building in Changsha. The investment mandate is broad, reflecting a founder-family office model rather than a dedicated healthcare fund.

The group is a willing co-investor when a partner brings operational expertise that complements its healthcare thesis. Its participation alongside KKR in Ruichen Pet Hospital Group demonstrates a preference for contributing local market knowledge and capital to deals led by global private equity firms. Separately, Hillhouse Capital and Temasek are known institutional shareholders in the listed Aier parent, though they invest at the operating-company level, not directly into the investment group.